TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel November 26, 1999
TCL Archive NCI Budget: About Half Of Increase In President’s Budget Would Fund Grants February 13, 1998